6 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2026-01-12.html
Changes: abemaciclib, trastuzumab, belumosudil mesilate, Lisocabtagene maraleucel, pembrolizumab
6 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2026-01-12.html
Changes: abemaciclib, trastuzumab, belumosudil mesilate, Lisocabtagene maraleucel, pembrolizumab
8 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2026-01-08.html
Changes: obinutuzumab, sacituzumab govitecan, fedratinib dihydrochloride monohydrate, imlifidase, abemac...
8 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2026-01-08.html
Changes: obinutuzumab, sacituzumab govitecan, fedratinib dihydrochloride monohydrate, imlifidase, abemac...
6 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2026-01-05.html
Changes: mycophenolate mofetil, paclitaxel albumin, talquetamab, obinutuzumab, sacituzumab govitecan
6 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2026-01-05.html
Changes: mycophenolate mofetil, paclitaxel albumin, talquetamab, obinutuzumab, sacituzumab govitecan
31 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2026-01-01.html
Changes: cyclophosphamide, durvalumab, methotrexate, nivolumab, axicabtagene ciloleucel, methotrexate d...
31 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2026-01-01.html
Changes: cyclophosphamide, durvalumab, methotrexate, nivolumab, axicabtagene ciloleucel, methotrexate d...
11 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-12-22.html
Changes: trastuzumab, isatuximab, Mirvetuximab soravtansine, cisplatin, thiotepa, brexucabtagene autole...
11 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-12-22.html
Changes: trastuzumab, isatuximab, Mirvetuximab soravtansine, cisplatin, thiotepa, brexucabtagene autole...
9 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-12-18.html
Changes: trastuzumab, capivasertib, olaparib, pentostatin, pembrolizumab, ciltacabtagene autoleucel, Mir...
9 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-12-18.html
Changes: trastuzumab, capivasertib, olaparib, pentostatin, pembrolizumab, ciltacabtagene autoleucel, Mir...
8 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-12-15.html
Changes: daratumumab, acalabrutinib maleate, bevacizumab, Futibatinib, capivasertib, trastuzumab
8 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-12-15.html
Changes: daratumumab, acalabrutinib maleate, bevacizumab, Futibatinib, capivasertib, trastuzumab
5 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-12-11.html
Changes: osimertinib mesylate, cemiplimab, daratumumab, acalabrutinib maleate
5 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-12-11.html
Changes: osimertinib mesylate, cemiplimab, daratumumab, acalabrutinib maleate
5 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-12-08.html
Changes: imatinib mesilate, azathioprine, eculizumab, osimertinib mesylate, cemiplimab
5 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-12-08.html
Changes: imatinib mesilate, azathioprine, eculizumab, osimertinib mesylate, cemiplimab
6 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-12-04.html
Changes: dinutuximab beta, apremilast, imatinib mesilate, azathioprine
6 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-12-04.html
Changes: dinutuximab beta, apremilast, imatinib mesilate, azathioprine
7 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-12-01.html
Changes: afatinib dimaleate, ibrutinib, dinutuximab beta, apremilast
7 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-12-01.html
Changes: afatinib dimaleate, ibrutinib, dinutuximab beta, apremilast
4 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-11-27.html
Changes: ciltacabtagene autoleucel, afatinib dimaleate, ibrutinib
4 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-11-27.html
Changes: ciltacabtagene autoleucel, afatinib dimaleate, ibrutinib
NHS England has updated the Cancer Drugs Fund List to version 1.379.
https://updates.chemo.org.uk/news/CDFNews_1.379.html
Changes - 👇 🧵
NHS England has updated the Cancer Drugs Fund List to version 1.379.
https://updates.chemo.org.uk/news/CDFNews_1.379.html
Changes - 👇 🧵
6 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-11-24.html
Changes: glatiramer acetate, melphalan hydrochloride, rozanolixizumab, ciltacabtagene autoleucel, afatin...
6 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-11-24.html
Changes: glatiramer acetate, melphalan hydrochloride, rozanolixizumab, ciltacabtagene autoleucel, afatin...
8 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-11-20.html
Changes: azathioprine, fluorouracil, mogamulizumab, bacillus calmette-guerin, daratumumab, glatiramer ac...
8 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-11-20.html
Changes: azathioprine, fluorouracil, mogamulizumab, bacillus calmette-guerin, daratumumab, glatiramer ac...
NHS England has updated the Cancer Drugs Fund List to version 1.378.
https://updates.chemo.org.uk/news/CDFNews_1.378.html
Changes - 👇 🧵
NHS England has updated the Cancer Drugs Fund List to version 1.378.
https://updates.chemo.org.uk/news/CDFNews_1.378.html
Changes - 👇 🧵
NHS England has updated the Cancer Drugs Fund List to version 1.377.
https://updates.chemo.org.uk/news/CDFNews_1.377.html
Changes - 👇 🧵
NHS England has updated the Cancer Drugs Fund List to version 1.377.
https://updates.chemo.org.uk/news/CDFNews_1.377.html
Changes - 👇 🧵
10 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-11-17.html
Changes: fingolimod hydrochloride, ruxolitinib phosphate, glofitamab, alpelisib, azathioprine, fluorour...
10 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-11-17.html
Changes: fingolimod hydrochloride, ruxolitinib phosphate, glofitamab, alpelisib, azathioprine, fluorour...
25 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-11-13.html
Changes: methotrexate, larotrectinib sulfate, methotrexate disodium, teclistamab, afatinib dimaleate, l...
25 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-11-13.html
Changes: methotrexate, larotrectinib sulfate, methotrexate disodium, teclistamab, afatinib dimaleate, l...
6 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-11-10.html
Changes: dimethyl fumarate, ropeginterferon alfa-2b, cisplatin, elranatamab, methotrexate
6 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-11-10.html
Changes: dimethyl fumarate, ropeginterferon alfa-2b, cisplatin, elranatamab, methotrexate
6 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-11-06.html
Changes: fluorouracil, Ublituximab, fulvestrant, melphalan hydrochloride, dimethyl fumarate, ropeginterf...
6 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-11-06.html
Changes: fluorouracil, Ublituximab, fulvestrant, melphalan hydrochloride, dimethyl fumarate, ropeginterf...
5 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-11-03.html
Changes: teriflunomide, bevacizumab, fluorouracil, fulvestrant
5 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-11-03.html
Changes: teriflunomide, bevacizumab, fluorouracil, fulvestrant
4 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-10-30.html
Changes: pertuzumab, apalutamide, teriflunomide, bevacizumab
4 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-10-30.html
Changes: pertuzumab, apalutamide, teriflunomide, bevacizumab
3 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-10-27.html
Changes: triptorelin acetate, pertuzumab, fluorouracil
3 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-10-27.html
Changes: triptorelin acetate, pertuzumab, fluorouracil
NHS England has updated the Cancer Drugs Fund List to version 1.376.
https://updates.chemo.org.uk/news/CDFNews_1.376.html
Changes - 👇 🧵
NHS England has updated the Cancer Drugs Fund List to version 1.376.
https://updates.chemo.org.uk/news/CDFNews_1.376.html
Changes - 👇 🧵